10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0000946644-14-000008`
Period End Date	20140331
Filing Date	20140509
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	heb-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 2 Cash Flow Statement 50 Stockholders Equity 9 Comprehensive Income 35

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$17.45M	USD	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$17.39M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$333.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$358.00K	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.55M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$21.89M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.89M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.05M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	168.66M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	183.29M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$990.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	183.29M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	168.66M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.08M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.11M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$136.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$136.00K	USD	Point-in-time
Total assets	`Assets`	$31.87M	USD	Point-in-time
Total assets	`Assets`	$35.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.74M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.23M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$33.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$31.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$23.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$15.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$14.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$14.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.02M	USD	Point-in-time
Commitments and contingencies (Notes 6,8,10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 6,8,10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 183,285,228 and 168,660,370, respectively	`CommonStockValue`	$168.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 183,285,228 and 168,660,370, respectively	`CommonStockValue`	$183.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$289.56M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$296.06M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-93.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-264.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-260.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.99M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$31.87M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$35.01M	USD	Point-in-time

Income Statement 2 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.61M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$167.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$179.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$4.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$165.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$89.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$121.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$88.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-25.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-29.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-16.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-358.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$512.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.13M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.90M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.85M	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$244.00K	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$46.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$75.00K	USD	1 Quarter
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	1 Quarter
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.53M	USD	1 Quarter
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$37.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$5.24M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-177.00K	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$13.00K	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$11.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$6.38M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.37M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.30M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-624.00K	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$134.00K	USD	1 Quarter
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$38.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$21.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$36.00K	USD	1 Quarter
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	-	USD	1 Quarter
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$49.00K	USD	1 Quarter

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.99M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$37.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$88.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$121.00K	USD	1 Quarter
Stock sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$6.38M	USD	1 Quarter
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-3.81M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.99M	USD	Point-in-time

Comprehensive Income 35 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$42.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$76.00K	USD	1 Quarter
Total revenues	`Revenues`	$42.00K	USD	1 Quarter
Total revenues	`Revenues`	$76.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$191.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$323.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.33M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.08M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$5.19M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$4.60M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.11M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.56M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$5.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$153.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$181.00K	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	Point-in-time
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$686.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$89.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.61M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$21.00K	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$45.00K	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$9.00K	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.58M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.81M	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	166.81M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	176.73M	shares	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.